fda semaglutide shortage resolved february 2025 announcement As of 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA declares end to Wegovy

Rybelsus can cause dizziness through several mechanisms: slowed gastric emptying leading to nausea and reduced food intake, improved glycaemic control potentially causing hypoglycaemia (especially with insulin or sulfonylureas), and modest reductions in blood pressure

The loading of inert drug carriers with anticancer agents and peptides which are able to bind (target) tumor-related proteins to enhance tumor drug accumulation and local cytotoxicity is a most promising approach

The company also sent text messages containing a link to cancel their subscription to the compounded semaglutide program to all users

Harlow SD, Gass M, Hall JE, et al

Frontiers in Cardiovascular Medicine, 10, 10230051

Track alcohol intake, weight, blood sugar, liver enzymes, and mood